Law Gregory Ivan

Avg. Two Year Performance

(67%) Avg. Purchase Return
(29%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return2%(2%)(43%)(73%)(67%)
Purchase Success Rate1 of 10 of 10 of 10 of 10 of 1
Average Sale Return----------
Sale Success Rate----------

Osiris Therapeutics, Inc.

Drugs » Biotechnology

Principal Accounting Officer:

Holdings: 100 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--